ESSA Pharma Inc Stock
Your prediction
ESSA Pharma Inc Stock
Our community identified positive and negative aspects for ESSA Pharma Inc stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the ESSA Pharma Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of ESSA Pharma Inc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of ESSA Pharma Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| ESSA Pharma Inc | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | -2.660% | 3.977% | -1.613% | 14.375% | 10.241% | 4.571% | -60.432% |
| Northwest Biotherapeutics Inc. | 0.000% | 38.462% | 12.500% | -18.919% | -12.621% | -59.641% | -81.053% |
| Achieve Life Sciences Inc. | 1.750% | 4.505% | 13.725% | 180.193% | 56.757% | 20.833% | -10.769% |
News
CNB Financial Q2 Earnings Call Highlights
Key Points
- Interested in CNB Financial Corporation? Here are five stocks we like better.
- CNB Financial reported strong Q2 results: Diluted EPS rose 49% year over year to $0.91, while operating
